Manon Laporte

9PUBLICATIONS
58CO-AUTHORS
HaematologyBiomolecular modelling and designMedical virologyGene and molecular therapyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 15, 2026
New determinant of influenza hemagglutinin cleavability identified through random mutagenesis for acid-stabilizing mutations.

|Mar 27, 2025
A coronavirus assembly inhibitor that targets the viral membrane protein.

Manon Laporte, Dirk Jochmans, Dorothée Bardiot

|Feb 26, 2025
The Combination of GS-441524 (Remdesivir) and Ribavirin Results in a Potent Antiviral Effect Against Human Parainfluenza Virus 3 Infection in Human Airway Epithelial Cell Cultures and in a Mouse Infection Model.

Yuxia Lin, Birgit Weynand, Xin Zhang

|Jan 25, 2025
Optimization of SARS-CoV-2 M<sup>pro</sup> Inhibitors by a Structure-Based Multilevel Virtual Screening Method.

Lanlan Jing, Fabao Zhao, Lin Zheng

|Oct 26, 2024
Efficacy of Integrase Strand Transfer Inhibitors and the Capsid Inhibitor Lenacapavir against HIV-2, and Exploring the Effect of Raltegravir on the Activity of SARS-CoV-2.

Irene Wanjiru Kiarie, Gyula Hoffka, Manon Laporte

|Sep 05, 2024
A robust mouse model of HPIV-3 infection and efficacy of GS-441524 against virus-induced lung pathology.

Yuxia Lin, Mona Khan, Birgit Weynand

Pageof 2

Frequent Collaborators

5 joint publications

Johan Neyts

5 joint publications

Annelies Stevaert

4 joint publications

Dirk Jochmans

4 joint publications

Lieve Naesens